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Tyrosinc phosphorylation in human blood lymphocytes was studied as a function of stimulation with concanavalin A (ConA) and treatmem of 
the cells with interferon a? (IFNa2) and/or an IFN-derived C-terminal synthetic pcptidc 2438 (amino acid residues 124-138). Both IFNa? and 
the prptide 2438 decreased the level of protein tyrosinc phosphorylation in the ConA-stimulated cells. In unstimulated cells, IFNaI) increased, and 
the peptide 2438 decreased the level of the tyrosinc phosphorylation. A possible correlation of these effects with stimulation of cell proliferation 
is discussed. 
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1. INTRODUCTION 
Activation of lymphocytes by antigens, mitogcnic 
lectins and numerous hormones results in rapid phos- 
phorylation of tyrosine, serine, and threonine residues 
of cellular proteins [l]. The role of protein tyrosinc 
phosphorylation in regulation of cellular activation, 
and identification or endogenous ubstrates of TPKs 
still remain an unsolved and important problem. 
In the present study we examined the effects of 
IFNa2 and the synthetic peptide 2438 on protein ty- 
rosine phosphorylation in human blood lymphocytes, 
and probed cellular substrates of TPKs with mono- 
clonai antibodies against P-Tyr [2]. 
It is known that IFNa may exert its biological ac- 
tivities using various pathways [3,4], but the detailed 
mechanisms,of its action are still far from clear. Previ- 
ously, we demonstrated that a short synthetic peptide 
(2438) representing the amino acid sequence 124-l 38 of 
the IFNor polypeptide chain, inhibited proliferation of 
human lymphocytes [5]. 
2. MATERIALS AND METHODS 
2. I. Morerids 
Human recombinant IFNor? (5 x IO” IU/mg) was a kind gift of Dr. 
Corr~sporrrlrrrcr rrci~/ress: A.V. Danilkosich. Department of Cellular 
Physiology and Immunology. Biological Faculty, Moscow State Uni- 
vcrsity, Lenin’s Hill, Moscow 119899. USSR. 
clbDreriurio,rs: ConA. concanavalin A: IF’Na?, interferon ~12; PBiviC, 
peripheral blood mononuclear cells; P.Tyr, phosphotyrosine: TPK, 
tyrosinc protein kinasc. 
G. Chipens (Instituu oforganic Synthesis, Riga, USSR). The peptide 
2438 was synthesized as described [6]. 
PBMC were obtained from normal human blood according to 
Boyum [7]. The cells (2 x 10” cells/ml/well) were incubated in 24-well 
tissue-culture plutcs (Nunc) in a 5% CO, atmosphere for I b at 37°C 
in complete RPM1 lG40 medium containing 5% heat-inactivated fetal 
calf serum. When necessary. ConA (2 m&ml) and IFNa2 (I.000 IUI 
ml). or the peplide 2438 ( IO4 M), or IFNa3 and the pcptidc wcrc 
added to the culture medium. After incubation. thecells werccollected 
and centrifuged, The pellet was lysed in the elcctrophoretic sample 
buffer [B]. 
Cellular proteins (4.10’ of lyscd cells) were elcctrophorescd in de- 
naturing 7.5-12.5% polyacrylamidc gradient slab gels according to 
Lacmmli [8], and electrophorctically transferred to nitrocellulosc 
filters using the semi-dry Western blotting tcchniquc [9]. Bands of 
P-Tyr containing proteins were stained with monoclonal antibodies 
against P-Tyr (clone B4). conjugated with horse radish pcroxidase. 
and I-chloro&naphtol as a substrate [2]. Individual tracks trlith P-Tyr 
containing prattin bands on nitroccllulosc sheets were scanned on an 
UltroScan XL Laser densitometer (LKB. &L&n). 
200 ml of PBMC suspension at a concentration of IOb celldml in a 
9G+cll Rat-bottom plate was cultured for 75 h in media containing 
ConA (2 mdml) in the presence of IFNrr? and/or the peplidc 2438. 
For the last I5 h of the culturing. [‘Hlthymidine (0.5 mCilwccll; 
AIIIerShdtn Corporation) was added. Cells were httrvCst& and the 
radioactivitv was measured in a liouid scintillation counter Rack-Beta 
(LKB-Wall& Swcdcn). ’ 
3. RESULTS AND DISCUSSION 
Several P-Tyr-containing proteins were detected in 
normal PBMC by Western blotting using anti-P-Tyr 
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Fig. 1, Western blot of separated polypcptides from human PBMC. 
Individual tracks demonstrate changes in tyrosinc phosphorylation 
level aFtcr treatment with different agents during I hour. Lanes: 
IFNa2. (2) 2438, (3) IFNa2 + 2438. (4) ConA, (5) ConA + IFNa2. (6) 
ConA + 2438, (7) ConA + IFNa? t 2438, and (8) control (medium 
alone). Left arrows, ~36 and ~56 respectively: right arrows, moleculnr 
weight mtirkcrs. 
antibodies (Fig. I), the dominant bands corresponding 
to molecular mass values of 56, 36, and between lo-20 
kDa. 
The 56.kDa protein may represent an autophospho- 
rylated form of tyrosine protein kinase ~~56’~“. 
Src-related tyrosine protein kinase pWck is detected 
in both human and murine T-cells. The activation of 
lymphocytes induces a rapid increase in the tyrosine- 
specific protein kinase activity of p561Ck and is associ- 
ated with autophosphorylation and phosphorylation of 
p561ck endogenous substrates [lo]. 
The 36-kDa protein has the same molecular mass 
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Fig. 2. Absorption of scanned area in individual tracks for p3G pbos- 
phorylated in presence of different agents. 
value as p36 (p35), which is known to be an endogenous 
protein substrate for several TPKs [l 11. 
Incubation of the cells with ConA, lFNa2, and the 
peptide 2438 in various combinations resulted in signif- 
icant changes of the level of the 36-kDa protein tyrosine 
phosphorylation, while the level of tyrosine phosphoryl- 
ation for the 56-kDa protein was unchanged (Figs. 1 
and 2). In particular, incubation of the cells with ConA 
alone leads to an essential increase in the 36-kDa pro- 
tein P-Tyr content. If the cells were incubated with 
ConA and IFNa2 simultaneously, the level of the 36- 
kDa protein tyrosine phosphorylation was markedly 
decreased. In the absence of ConA, IFNa2 had no effect 
on tyrosine phosphorylation. Irrespective of the pres- 
ence of ConA, the peptide 2438 reduced the level of 
P-Tyr content in the 36-kDa protein, the effect being 
partially compensated for by addition of IFNa2. 
IFNa2 and/or the peptide 2438 inhibit the stimula- 
tion of PBMC proliferation by ConA (Fig. 3). In the 
absence of ConA, the proliferation is insensitive to 
IFNa2 and/or the peptide 2438 (not shown). 
It appears that the effects of IFNa2 and the peptide 
2438 on cellular proliferation (Fig. 3) and P-Tyr content 
in the 36-kDa protein (Fig. 2) in the presence of ConA 
could be interrelated, although the simultaneous addi- 
tion of IFNa2 and the peptide leads to a synergistic 
effect on proliferation (Fig. 3), and antagonistic one on 
the 36-kDa protein tyrosine phosphorylation level (Fig. 
2). The decline of tyrosine phosphoryiation of the 36- 
kDa protein under treatment of the cells with IFNa2 
and/or the peptide 2438 could be explained by inhibition 
of TPKs and/or activation of P-Tyr specific 
phosphatases. 
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